Evidence method
Level · gp.fundamentals.capex_revenue_ratio
59.61% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CRBU · Mar 31, 2024
Caribou Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001619856-24-000038General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1531.62% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-30.64% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-1893.87% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1391.03% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
164.18% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Dec 31, 20230/6 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/6 normalizedLevel 3Dec 31, 20245/6 normalizedLevel 3Mar 31, 20255/6 normalizedLevel 3Jun 30, 20255/6 normalizedLevel 3Sep 30, 20255/6 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20266/6 normalizedLevel 3Jun 30, 20266/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 33.68%
- Current
- 59.61%
- Delta
- 25.93%
- Previous
- -270.59%
- Current
- -1531.62%
- Delta
- -1261.03%
- Previous
- 148.91%
- Current
- -30.64%
- Delta
- -179.55%
- Previous
- -336.63%
- Current
- -1893.87%
- Delta
- -1557.24%
- Previous
- 325.07%
- Current
- 1391.03%
- Delta
- 1065.95%
- Previous
- 39.88%
- Current
- 164.18%
- Delta
- 124.30%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CRBU Fundamental State →Has State · Caribou Biosciences, Inc. →Transitioned To · CRBU Fundamental State →Transitioned To · CRBU CAPEX_INTENSITY_INCREASED →Transitioned To · CRBU CASH_GENERATION_DECREASED →Transitioned To · CRBU GROWTH_DECREASED →Transitioned To · CRBU PROFITABILITY_DECREASED →Transitioned To · CRBU R_AND_D_INTENSITY_INCREASED →Transitioned To · CRBU SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.